Galectin Therapeutics Inc (FRA:PHPN)
€ 2.38 0.04 (1.71%) Market Cap: 151.00 Mil Enterprise Value: 213.71 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 38/100

Galectin Therapeutics Inc Annual Shareholders Meeting Transcript

Dec 07, 2023 / 04:00PM GMT
Release Date Price: €1.72 (-1.15%)
Operator

Thank you, ladies and gentlemen. Welcome to the Galectin Therapeutics Inc., 2023 Annual Meeting call. I would now like to welcome Kevin.

Kevin Freeman Galectin Therapeutics Inc;Vice Chairman of the Board

Good morning, ladies and gentlemen, and welcome. My name is Kevin Freeman. I'm the Vice Chairman of the Board of Galectin Therapeutics Inc. I will act as Chair of the meeting. And Mr. Jack Callicutt, our Chief Financial Officer and Corporate Secretary, will act as Secretary.

Due to the cost savings and other efficiencies, we are holding this year's annual meeting as a virtual meeting. Stockholders who require technical assistance during the meeting can call Broadridge's technical support line at the number listed on our virtual meeting website. Thank you.

I hereby call the 2023 Annual Meeting for Galectin Therapeutics Inc. to order. At this time, I would like to introduce the current members of the Board of Directors: Dr. Gilbert Amelio, Director, Member of the Compensation Committee, and Chair of the Nominating and Corporate

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot